Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CVS
What Tidings From the Tetons? Long-Awaited Yellen Speech Today
Analysts At Argus Review CVS Q2 Earnings
Mylan Expands Discount Program For EpiPen; PBM Stocks Under Pressure (Investor's Business Daily)
Related RM
Benzinga's Top Upgrades
Benzinga's Volume Movers

Analysts at Cantor Fitzgerald downgraded CVS (NYSE: CVS) from “buy” to “hold.” The target price for CVS has been lowered from $65 to $62. CVS's shares closed at $59.89 yesterday.

Jefferies downgraded Regional Management (NYSE: RM) from “buy” to “hold.” The target price for Regional Management is set to $29. Regional Management's shares closed at $31.20 yesterday.

Bank of America downgraded Marathon Oil (NYSE: MRO) from “buy” to “neutral.” The target price for Marathon Oil has been lowered from $45 to $42. Marathon Oil's shares closed at $36.88 yesterday.

Analysts at McNicoll Lewis Vlak downgraded ACADIA Pharmaceuticals (NASDAQ: ACAD) from “buy” to “hold.” The target price for ACADIA Pharmaceuticals has been raised from $18 to $20. ACADIA's shares closed at $20.68 yesterday.

Latest Ratings for CVS

DateFirmActionFromTo
Aug 2016CitigroupMaintainsNeutral
Aug 2016Deutsche BankMaintainsHold
Jun 2016Morgan StanleyDowngradesEqual-weight

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ACAD + CVS)

View Comments and Join the Discussion!